An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Drug Reaction Chemically-Induced Disorders Drug Abuse Drug Hypersensitivity Drug Interaction Drug-Related Side Effects and Adverse Reactions Mental Disorders Substance-Related Disorders

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Deraya university

Minya, 05673, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all health care providers are invited to share in the study
minimum experience required is one year in health carrier.
accept sharing in the study

Exclusion criteria

health care providers who refuse to complete all data required in the survey.
fresh experience or participants who left health carrier

Treatment and study plan

questionner

Other

three sections questioner including: demographics, reported cases, unreported cases

Primary outcomes

reported adverse drug reactions

Time frame: 3 months

collect recent adverse drug reaction reports

Sponsors and collaborators

Lead sponsor

Deraya University

Other

Registry information

Official study title

an Observational Study for the Prevalence of Pharmacovigilance Practices Between Healthcare Providers in North African Nation

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: May 24, 2024
Registry last updated: Aug 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed